Etanercept for pemphigus vulgaris

Ital J Dermatol Venerol. 2021 Dec;156(Suppl. 1 to No. 6):10-11. doi: 10.23736/S2784-8671.18.06204-1. Epub 2019 Jan 9.

Authors

Francesco Savoia¹, Michela Tabanelli², Andrea Sechi³, Carlotta Baraldi¹, Federico Bardazzi¹, Annalisa Patrizi¹

Affiliations

¹ Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
² Unit of Dermatology, AUSL Romagna, Ravenna, Italy.
³ Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy - andrea.sechi@hotmail.com.

PMID: 30636400
DOI: 10.23736/S2784-8671.18.06204-1

No abstract available

MeSH terms

Etanercept / therapeutic use
Humans
Immunoglobulin G / therapeutic use
Pemphigus* / drug therapy
Tumor Necrosis Factor-alpha

Substances

Immunoglobulin G
Tumor Necrosis Factor-alpha
Etanercept